HighMark Wealth Management’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69 | Hold |
287
| – | – | ﹤0.01% | 607 |
|
|
2025
Q1 | $57 | Hold |
287
| – | – | ﹤0.01% | 564 |
|
|
2024
Q4 | $155 | Hold |
287
| – | – | ﹤0.01% | 554 |
|
|
2024
Q3 | $273 | Hold |
287
| – | – | ﹤0.01% | 562 |
|
|
2024
Q2 | $280 | Hold |
287
| – | – | ﹤0.01% | 555 |
|
|
2024
Q1 | $453 | Hold |
287
| – | – | ﹤0.01% | 529 |
|
|
2023
Q4 | $228 | Hold |
287
| – | – | ﹤0.01% | 552 |
|
|
2023
Q3 | $224 | Sell |
287
-982
| -77% | -$766 | ﹤0.01% | 543 |
|
|
2023
Q2 | $1.17K | Buy |
+1,269
| New | +$1.17K | ﹤0.01% | 492 |
|